Your browser doesn't support javascript.
loading
Novel modes of MPL activation in triple-negative myeloproliferative neoplasms.
Samaraweera, Saumya E; Geukens, Tatjana; Casolari, Debora A; Nguyen, Tran; Sun, Caitlyn; Bailey, Sheree; Moore, Sarah; Feng, Jinghua; Schreiber, Andreas W; Parker, Wendy T; Brown, Anna L; Butcher, Carolyn; Bardy, Peter G; Osborn, Michael; Scott, Hamish S; Talaulikar, Dipti; Grove, Carolyn S; Hahn, Christopher N; D'Andrea, Richard J; Ross, David M.
Afiliação
  • Samaraweera SE; Centre for Cancer Biology, SA Pathology and University of South Australia, Adelaide, SA, Australia.
  • Geukens T; Centre for Cancer Biology, SA Pathology and University of South Australia, Adelaide, SA, Australia; Department of Oncology, KU Leuven, Leuven, Belgium.
  • Casolari DA; Centre for Cancer Biology, SA Pathology and University of South Australia, Adelaide, SA, Australia.
  • Nguyen T; Centre for Cancer Biology, SA Pathology and University of South Australia, Adelaide, SA, Australia.
  • Sun C; Department of Haematology, Royal Adelaide Hospital, Adelaide, SA, Australia; Adelaide Medical School, The University of Adelaide, Adelaide, SA, Australia.
  • Bailey S; UniSA Clinical and Health Sciences, University of South Australia, Adelaide, SA, Australia; Health and Biomedical Innovation, Clinical and Health Sciences, University of South Australia, Adelaide, SA, Australia.
  • Moore S; Department of Genetics and Molecular Pathology, SA Pathology, Adelaide, SA, Australia.
  • Feng J; Centre for Cancer Biology, SA Pathology and University of South Australia, Adelaide, SA, Australia; ACRF Cancer Genomics Facility, SA Pathology, Adelaide, SA, Australia.
  • Schreiber AW; Centre for Cancer Biology, SA Pathology and University of South Australia, Adelaide, SA, Australia; UniSA Clinical and Health Sciences, University of South Australia, Adelaide, SA, Australia; ACRF Cancer Genomics Facility, SA Pathology, Adelaide, SA, Australia; School of Biological Sciences, The Uni
  • Parker WT; Department of Genetics and Molecular Pathology, SA Pathology, Adelaide, SA, Australia.
  • Brown AL; Centre for Cancer Biology, SA Pathology and University of South Australia, Adelaide, SA, Australia; Adelaide Medical School, The University of Adelaide, Adelaide, SA, Australia; Department of Genetics and Molecular Pathology, SA Pathology, Adelaide, SA, Australia.
  • Butcher C; Department of Haematology, Royal Adelaide Hospital, Adelaide, SA, Australia.
  • Bardy PG; Department of Haematology, Royal Adelaide Hospital, Adelaide, SA, Australia.
  • Osborn M; South Australia/Northern Territory Youth Cancer Service, Royal Adelaide Hospital, Adelaide, SA, Australia; Department of Haematology and Oncology, Women's and Children's Hospital, North Adelaide, SA, Australia.
  • Scott HS; Centre for Cancer Biology, SA Pathology and University of South Australia, Adelaide, SA, Australia; Adelaide Medical School, The University of Adelaide, Adelaide, SA, Australia; UniSA Clinical and Health Sciences, University of South Australia, Adelaide, SA, Australia; Department of Genetics and Mol
  • Talaulikar D; Haematology Translational Research Unit, ACT Pathology, Canberra Hospital, Canberra, ACT, Australia.
  • Grove CS; Department of Haematology, Sir Charles Gairdner Hospital and PathWest, Perth, WA, Australia.
  • Hahn CN; Centre for Cancer Biology, SA Pathology and University of South Australia, Adelaide, SA, Australia; Adelaide Medical School, The University of Adelaide, Adelaide, SA, Australia; UniSA Clinical and Health Sciences, University of South Australia, Adelaide, SA, Australia; Department of Genetics and Mol
  • D'Andrea RJ; Centre for Cancer Biology, SA Pathology and University of South Australia, Adelaide, SA, Australia.
  • Ross DM; Centre for Cancer Biology, SA Pathology and University of South Australia, Adelaide, SA, Australia; Department of Haematology, Royal Adelaide Hospital, Adelaide, SA, Australia; Adelaide Medical School, The University of Adelaide, Adelaide, SA, Australia; Department of Haematology and Genetic Patholo
Pathology ; 55(1): 77-85, 2023 Feb.
Article em En | MEDLINE | ID: mdl-36031433
Assuntos
Palavras-chave
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Transtornos Mieloproliferativos / Neoplasias Limite: Humans Idioma: En Revista: Pathology Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Austrália País de publicação: Reino Unido
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Transtornos Mieloproliferativos / Neoplasias Limite: Humans Idioma: En Revista: Pathology Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Austrália País de publicação: Reino Unido